BusinessWorld reports a Wegovy price cut in China as competition in the weight loss drug market there heats up. Figures are in the full report.
Recap by typeshit. Full story at BusinessWorld Online.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
KTSM breaks down which Medicare enrollees are eligible for GLP-1 drugs at a $50 monthly cost.
Men's Journal looks at the extra spending that comes with GLP-1 drugs beyond the prescription price, as these meds reshape weight loss.
The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
Penn State's Eberly College of Science says the funding will help Schissel use AI to spot synthetic peptides useful for new drugs.
Exercise advice aimed at people on GLP-1 medication, shared without further detail on the specific workouts recommended.
Loading…